Company Analysis

Curis, Inc. (CRIS)

Nasdaq: CRIS · Biological Products, (No Diagnostic Substances) · Lexington, MA · filing with the SEC since 2000
Grade4.1
◀ Past 3.4● Present 4.1▶ Future 4.5
1 est.

Who runs Curis, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Dentzer James E
President & CEO. First filing Mar 2016, latest Jul 9, 2026, 4 filings in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
18 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Dentzer James EPresident & CEOMar 2016Jul 9, 2026none
Duvall DianthaCFOAug 2022Jul 9, 2026none
Zung Jonathan B.CDOMay 2023Jul 9, 2026none
Hamdy Ahmed MdCMOMay 2025Mar 23, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Borgman Anne ElizabethdirectorOct 2022Jul 9, 2026none
Greenacre Martyn DdirectorJun 2006Jul 9, 2026none
Hohneker JohndirectorDec 2021Jul 9, 2026none
Kaitin Kenneth IdirectorJun 2006Jul 9, 2026none
Rubin MarcdirectorJun 2010Jul 9, 2026none
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CRIS · research, not advice